These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31639768)

  • 1. Strategies to Investigate Biotin Interference in Light of the FDA Safety Communication.
    Johnson L; Li D
    J Appl Lab Med; 2019 Mar; 3(5):914-915. PubMed ID: 31639768
    [No Abstract]   [Full Text] [Related]  

  • 2. Best practices in mitigating the risk of biotin interference with laboratory testing.
    Bowen R; Benavides R; Colón-Franco JM; Katzman BM; Muthukumar A; Sadrzadeh H; Straseski J; Klause U; Tran N
    Clin Biochem; 2019 Dec; 74():1-11. PubMed ID: 31473202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond rapid cycle: a one-day safety summit tool to prevent mislabeled laboratory specimens.
    Maund T; Espinosa J; Kosnik L
    Jt Comm J Qual Improv; 2002 Mar; 28(3):127-8. PubMed ID: 11902027
    [No Abstract]   [Full Text] [Related]  

  • 4. The biotin interference within interference suppressed immunoassays.
    Kabiri P; Weiskirchen R; van Helden J
    J Clin Lab Anal; 2021 Sep; 35(9):e23940. PubMed ID: 34346119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center.
    Stieglitz HM; Korpi-Steiner N
    Clin Biochem; 2020 Jan; 75():53-61. PubMed ID: 31677994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders.
    Wolf B
    Mol Genet Metab; 2019 Aug; 127(4):321-324. PubMed ID: 31320189
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotin interference: Underrecognized patient safety risk in laboratory testing.
    Gifford JL; Sadrzadeh SMH; Naugler C
    Can Fam Physician; 2018 May; 64(5):370. PubMed ID: 29760259
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotin interference in immunoassay: a review for the laboratory scientist.
    Avery G
    Ann Clin Biochem; 2019 Jul; 56(4):424-430. PubMed ID: 31023057
    [No Abstract]   [Full Text] [Related]  

  • 9. Blackboard basics for Lab 101.
    Beall A; Tiffany D; Isabel JM; Ballance LO
    MLO Med Lab Obs; 2007 Mar; 39(3):12, 14, 16 passim; quiz 26-7. PubMed ID: 17447675
    [No Abstract]   [Full Text] [Related]  

  • 10. Combating inaccuracy and inefficiency in the lab Tips for using logistics to avoid quality control issues.
    Boykin K
    MLO Med Lab Obs; 2016 Oct; 48(10):44. PubMed ID: 30047657
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolving hyperthyroidism?
    Meng QH
    Clin Biochem; 2020 Jan; 75():83-84. PubMed ID: 31765636
    [No Abstract]   [Full Text] [Related]  

  • 12. Reducing Specimen Errors.
    AORN J; 2019 Apr; 109(4):496-499. PubMed ID: 30919426
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical Specimen Management: A Descriptive Study of 648 Adverse Events and Near Misses.
    Steelman VM; Williams TL; Szekendi MK; Halverson AL; Dintzis SM; Pavkovic S
    Arch Pathol Lab Med; 2016 Dec; 140(12):1390-1396. PubMed ID: 27610645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altmetric analysis of biotin in scholarly outputs after the biotin Food and Drug Administration warning.
    Chang MJ; Lipner SR
    J Am Acad Dermatol; 2020 Apr; 82(4):1017-1018. PubMed ID: 31765680
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of sample dilution on two free light chain nephelometric assays.
    Jacobs JF; Hoedemakers RM; Teunissen E; van der Molen RG; te Velthuis H
    Clin Chim Acta; 2012 Oct; 413(19-20):1708-9. PubMed ID: 22588162
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved Specimen-Referral System and Increased Access to Quality Laboratory Services in Ethiopia: The Role of the Public-Private Partnership.
    Kebede Y; Fonjungo PN; Tibesso G; Shrivastava R; Nkengasong JN; Kenyon T; Kebede A; Gadde R; Ayana G
    J Infect Dis; 2016 Apr; 213 Suppl 2(Suppl 2):S59-64. PubMed ID: 27025700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical-Immunological Examination].
    Seimiya M
    Rinsho Byori; 2015 Dec; 63(12):1377-86. PubMed ID: 27089654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for mitigating risk posed by biotin interference on clinical immunoassays.
    Gifford JL; de Koning L; Sadrzadeh SMH
    Clin Biochem; 2019 Mar; 65():61-63. PubMed ID: 30582902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finding control in quality control of unit-use prothrombin time tests.
    Pontius CA
    MLO Med Lab Obs; 2001 May; 33(5):38-40, 42. PubMed ID: 11373813
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotin: an emerging analytical interference.
    Piketty ML; Souberbielle JC
    Ann Biol Clin (Paris); 2017 Aug; 75(4):366-368. PubMed ID: 28751281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.